ACM Research, Inc. has completed an IPO and has been listed on NASDAQ
ACM Research, Inc.(ACM) has been listed on NASDAQ through an IPO to enhance its brand image, solidify IP protection and function as a global platform for future acquisitions.
ACM Research, Inc. develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. The company’s Ultra C equipment is designed to remove random defects from a wafer surface effectively, without damaging a wafer or its features, even at an increasingly advanced process node (the minimum line width on a chip) of 22 nanometers, or less. ACM’s equipment is based on its innovative proprietary Space Alternated Phase Shift (SAPS) and Timely Energized Bubble Oscillation (TEBO) technologies. ACM developed proprietary technologies to enable manufacturers to produce chips that reach their ultimate physical limitations while maintaining product yield, which is the percentage of chips on a wafer that meet manufacturing specifications. The company, founded in 1998 and headquartered in Fremont, California, markets and sells its products through direct sales force and third-party representatives.
Oaklins’ team in Shanghai assisted ACM's management team and shareholders through the whole process to the successful completion of an IPO and subsequent listing on NASDAQ.
Talk to the deal team
Related deals
Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreDuke Capital Limited has completed a fundraising
Duke Capital Limited has completed a successful fundraise, securing US$29.8 million (£23.5 million) through a placing and retail offer on the Alternative Investment Market (AIM). This milestone will further enable Duke Capital to continue its innovative approach to alternative financing solutions for small and medium enterprises (SMEs) across the UK and Europe.
Learn more